1. Home
  2. UFG vs PASG Comparison

UFG vs PASG Comparison

Compare UFG & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uni-Fuels Holdings Limited

UFG

Uni-Fuels Holdings Limited

HOLD

Current Price

$0.78

Market Cap

29.7M

Sector

Energy

ML Signal

HOLD

PASG

Passage Bio Inc.

HOLD

Current Price

$5.20

Market Cap

26.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFG
PASG
Founded
2021
2017
Country
Singapore
United States
Employees
17
27
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.7M
26.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
UFG
PASG
Price
$0.78
$5.20
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$14.00
AVG Volume (30 Days)
102.5K
137.8K
Earning Date
04-22-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.95
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$211.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.28
52 Week High
$9.91
$20.00

Technical Indicators

Market Signals
Indicator
UFG
PASG
Relative Strength Index (RSI) 38.33 41.63
Support Level $0.78 $3.94
Resistance Level $1.02 $7.76
Average True Range (ATR) 0.07 0.46
MACD -0.01 0.13
Stochastic Oscillator 5.67 63.79

Price Performance

Historical Comparison
UFG
PASG

About UFG Uni-Fuels Holdings Limited

Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Share on Social Networks: